Leukocytapheresis Device Market to Experience Significant Growth During the Forecast Period 2018 to 2028
Leukocytapheresis device is used in a nonsurgical treatment to reduce the quantity of white blood cells in the bloodstream. It may be indicated in patients with leukostasis which is resulted from microvascular obstruction by the white blood cells and may lead to hemorrhage in various tissues and organs. Leukocytapheresis device is increasingly adopted in the treatment for leukostasis to quickly reduce the white blood cell count. Additionally, the leukocytapheresis device is used to reverse the symptoms of severe inflammatory bowel disease...
View full press release